4.7 Review

Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 128, Issue -, Pages 29-53

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2018.04.001

Keywords

Microfluidics; Drug delivery; Nanotechnology; Nanomedicine; Organ-on-a-chip; 3D culture

Funding

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A1A09005662, 2016R1A4A1010796]
  2. American Heart Association National Scientist Development Grant [15SDG25080314]
  3. National Science Foundation CAREER award [CMMI 1653006]

Ask authors/readers for more resources

Microfluidic technologies employ nano and microscale fabrication techniques to develop highly controllable and reproducible fluidic microenvironments. Utilizing microfluidics, lead compounds can be produced with the controlled physicochemical properties, characterized in a high-throughput fashion, and evaluated in in vitro biomimetic models of human organs; organ-on-a-chip. As a step forward from conventional in vitro culture methods, microfluidics shows promise in effective preclinical testing of nanoparticle-based drug delivery. This review presents a curated selection of state-of-the-art microfluidic platforms focusing on the fabrication, characterization, and assessment of nanoparticles for drug delivery applications. We also discuss the current challenges and future prospects of nanoparticle drug delivery development using microfluidics. (C) 2018 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available